Key result
Early blood pressure control is linked to ~28% lower all-cause mortality in patients under 55.
Why the study?
Hypertension is a leading modifiable risk factor for cardiovascular disease, but the association between good blood pressure control measured by time in therapeutic range during the first year after diagnosis and kidney or cardiovascular events and mortality was assessed.
Does good blood pressure control, measured by time in therapeutic range during the first year after diagnosis, reduce mortality and kidney/cardiovascular events in newly diagnosed hypertensive patients?
Cohort (n=38,002)
Yes
Does good blood pressure control, measured by time in therapeutic range during the first year after diagnosis, reduce mortality and kidney/cardiovascular events in newly diagnosed hypertensive patients?
Achieving good blood pressure control (measured by time in therapeutic range) during the first year of hypertension diagnosis significantly reduces long-term mortality and cardiovascular/kidney events in patients under 75 years of age.
Background Hypertension is one of the leading modifiable risk factors for cardiovascular disease. This study assessed the association between good blood pressure control (GBPC), measured by time in therapeutic range (TTR) during the first year after hypertension diagnosis, and kidney or cardiovascular (K/CV) events and mortality in a large real-world cohort. Methods This population-based retrospective cohort included adults newly diagnosed with hypertension in primary care in Madrid, Spain, between 2007 and 2008, with no previous K/CV disease. Participants were identified from electronic medical records; outcomes were recorded until December 31, 2018, death, or deregistration. TTR during the first year was calculated using the indirect (iTTR; proportion of follow-up time within the BP target range) and direct (dTTR; proportion of BP measurements within the BP target range) methods. GBPC was defined as the highest TTR quartile (≥ 81% for iTTR and ≥ 67% for dTTR) or the last office BP measurement < 140/90 mmHg. Associations with mortality and K/CV events were evaluated using Cox regression models. Results A total of 38,002 patients were included (median age, 59 years [IQR, 49–69]; 53.9% women), with a median follow-up of 130.6 months (IQR, 123.1–137.3). During follow-up, 3,947 patients died (899 from K/CV causes), yielding an all-cause mortality rate of 8.24 per 10,000 person-months. A total of 11,727 K/CV events occurred, including 401 deaths. After adjustment for covariates, GBPC was associated with a 28% lower risk of all-cause mortality (95% CI, 5–45%) in patients diagnosed before 55 years (iTTR) and a 10% lower risk (95% CI, 0–20%) in those aged 55–74 years (iTTR and dTTR). GBPC was also associated with lower K/CV risk in patients aged < 55 years (11% [95% CI, 1–20%] for iTTR and 17% [95% CI, 8–25%] for dTTR) and 55–74 years (11% [95% CI, 6–16%] for iTTR and 10% [95% CI, 4–14%] for dTTR). No significant associations were observed at ≥ 75 years. Conclusion Good blood pressure control during the first year after diagnosis, defined using TTR and a BP target of < 140/90 mmHg, was associated with lower risks of mortality and K/CV events among patients diagnosed before age 75 years.
No takes yet. Share an insight, caveat, or question.
Alonso‐Safont et al. (2026) conducted a cohort in Hypertension (n=38,002). Good blood pressure control (GBPC) during the first year vs. Poor blood pressure control was evaluated on All-cause mortality (patients <55 years, iTTR) (HR 0.72, 95% CI 0.55-0.95, p=<0.05). Good blood pressure control during the first year after diagnosis was associated with a 28% lower risk of all-cause mortality in patients under 55 years and a 10% lower risk in those aged 55-74 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: